NovoCure (NVCR) Enterprise Value (2014 - 2026)
NovoCure (NVCR) posted Enterprise Value of -$440.6 million for Q2 2026, down 1.98% sequentially from -$432.0 million in Q1 2026, and up 51.67% YoY from -$290.5 million in Q2 2025.
NovoCure (NVCR) Enterprise Value (2014 - 2026) Analysis & Trends
NovoCure has reported Enterprise Value for 13 years, with the latest figure at -$440.6 million in Q2 2026.
- Quarterly Enterprise Value rose 51.67% year-over-year to -$440.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$440.6 million (up 51.67% YoY) and the FY2025 annual result came in at -$447.7 million, up 53.36% from the prior year.
- Enterprise Value declined to -$440.6 million in Q2 2026 per NVCR's latest filing, from -$432.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$432.0 million in Q1 2026 and troughed at -$1.0 billion in Q3 2025.
- A 5-year average of -$860.4 million and a median of -$936.6 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value slipped 7.86% in 2022, then jumped 53.5% in 2026.
- Over 5 years, Enterprise Value stood at -$969.4 million in 2022, then climbed by 6.07% to -$910.6 million in 2023, then dropped by 5.41% to -$959.9 million in 2024, then surged by 53.36% to -$447.7 million in 2025, then increased by 1.59% to -$440.6 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$440.6 million, -$432.0 million, and -$447.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -467.80 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | -440.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -440.56 Mn |
| Mar 31, 2026 | -432.00 Mn |
| Dec 31, 2025 | -447.67 Mn |
| Sep 30, 2025 | -1.03 Bn |
| Jun 30, 2025 | -911.53 Mn |
| Mar 31, 2025 | -929.13 Mn |
| Dec 31, 2024 | -959.87 Mn |
| Sep 30, 2024 | -959.90 Mn |
| Jun 30, 2024 | -951.19 Mn |
| Mar 31, 2024 | -870.15 Mn |
| Dec 31, 2023 | -910.62 Mn |
| Sep 30, 2023 | -921.25 Mn |
| Jun 30, 2023 | -940.82 Mn |
| Mar 31, 2023 | -958.04 Mn |
| Dec 31, 2022 | -969.43 Mn |
| Sep 30, 2022 | -970.32 Mn |
| Jun 30, 2022 | -948.52 Mn |
| Mar 31, 2022 | -932.30 Mn |
| Dec 31, 2021 | -937.70 Mn |
| Sep 30, 2021 | -933.79 Mn |